Content
All Posts > Content under Private Equity & Venture Capital
Week In Review: China Resources And Charoen Pokphand Join To Launch $300 Million Life Science Fund
Article By:
ChinaBio® Today
Read
Sunday, February 10, 2019 5:00 AM EDT
This week in Chinese biotech: new funding sources, startups funded, licensing news, trials and approvals.
The Amazing Retail Cannabis Boom
Article By:
Adam Sharp
Read
Saturday, February 9, 2019 9:48 AM EDT
There’s never been a market like this before. It’s going to be a wild ride for the next few years, but those who buy and hold high-quality companies should do incredibly well.
$1.1 Trillion Fund Is Buying Everything With Fed At "Market's Mercy"
Article By:
Tyler Durden
Read
Sunday, January 27, 2019 5:39 PM EDT
Earlier this month, when the Fed released full transcripts from its 2013 FOMC meetings, there was a moment of epiphany by Chair Jerome Powell, when he unveiled what markets have known all along: that the Fed is hostage to the market's every whim.
"It’s Terrible Out There": Lack Of Greater Shale Fools Leaves Private Equity In A Bidless Panic
Article By:
Tyler Durden
Read
Saturday, January 26, 2019 8:23 PM EDT
On one hand the US shale industry has never had it better but this production glut blessing is also a curse, and according to one industry titan, US production growth could slow by as much as half this year.
Week In Review: Yantai's MabPlex Raises $59 Million To Expand CDMO Services
Article By:
ChinaBio® Today
Read
Sunday, January 20, 2019 10:38 AM EDT
MabPlex, a biologics CDMO, raised $59 million in a Series A round from SDIC Venture Fund and Shenzhen Venture Capital. MabPlex offers biologics development and manufacturing services, including mAbs, recombinant proteins, ADCs and bispecifics.
Hedge Funds In Venture Capitalist Clothing
Article By:
AllAboutAlpha
Read
Sunday, January 6, 2019 1:17 PM EDT
A new study of hedge funds that are engaged in venture capital contends that some successfully exploit their expertise in the value of the publicly owned portion of specific industries when they enter the private/venture side of the same industries.
Week In Review: Shanghai Industrial To Start $7.3 Billion Biomedical Fund In 2019
Article By:
ChinaBio® Today
Read
Saturday, December 29, 2018 4:08 PM EDT
Shanghai Industrial Investment, a state-owned conglomerate, plans to launch a $7.3 billion equity fund for China biopharma investments. The company plans to begin raising $1.5 billion in January for the fund's first tranche.
Despite Abysmal Performance, Hedge Fund Traders Expect 16% Pay Raise
Article By:
Tyler Durden
Read
Friday, December 14, 2018 7:10 PM EDT
While the S&P is flirting with unchanged territory on the year, for hedge funds 2018 was a year they would all rather forget ever happened: not only is the HFRX hedge fund index down 6.3% YTD, its worst annual performance since Q3 2011.
Week In Review: Alphamab Closes $100 Million Series A For Oncology Candidates
Article By:
ChinaBio® Today
Read
Saturday, November 24, 2018 4:09 PM EDT
Alphamab Oncology, a clinical-stage Suzhou biopharma, completed a Series A funding with over $100 million in capital. Earlier this year, Alphamab Oncology was spun out of Suzhou Alphamab with seven oncology assets and related technology platforms.
Quantifying High Performance Dispersion Risk In Alternatives
Article By:
AllAboutAlpha
Read
Friday, October 26, 2018 2:45 AM EDT
Lofty valuations in traditional assets have encouraged investors to explore alternatives. Unfortunately, the lack of a holistic investment framework to incorporate alternatives poses a challenge.
Funding Secured
Article By:
Ben Hunt
Read
Sunday, October 21, 2018 1:35 PM EDT
Can you imagine if Tesla were moving forward with the Saudi sovereign wealth fund in a take-private transaction? Can you imagine the uproar over doing this sort of major deal with the Saudis after the Khashoggi murder? Well, no need to imagine.
In this article: WE